Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| Hs 578T | Palbociclib | 3.1623 | uM | 1 | 625.00 | 382.17 | 682.67 | 1678.83 | 0.4567 | 45813.4075 |
| Hs 578T | Methotrexate | 3.1623 | uM | 1 | 1250.00 | 718.46 | 1629.67 | 2335.33 | 0.6928 | 0.5948 |
| Hs 578T | Methotrexate | 3.1623 | uM | 1 | 625.00 | 382.17 | 957.67 | 1678.83 | 0.6760 | 1.9906 |
| Hs 578T | NVP-TAE684 | 3.1623 | uM | 1 | 625.00 | 382.17 | 270.33 | 1080.08 | 0.2505 | -0.2235 |
| Hs 578T | Omipalisib | 3.1623 | uM | 1 | 625.00 | 382.17 | 421.00 | 1678.83 | 0.2353 | 841813822472000.0000 |
| Hs 578T | Omipalisib | 3.1623 | uM | 1 | 1250.00 | 718.46 | 791.67 | 2335.33 | 0.3234 | -0.0066 |
| Hs 578T | Etoposide | 3.1623 | uM | 1 | 312.50 | 222.17 | 245.67 | 682.08 | 0.3639 | 0.0631 |
| Hs 578T | NVP-TAE684 | 3.1623 | uM | 1 | 312.50 | 222.17 | 196.33 | 682.08 | 0.2895 | -0.0771 |
| Hs 578T | Nilotinib | 3.1623 | uM | 1 | 625.00 | 382.17 | 1100.00 | 1080.08 | 1.0021 | 0.9794 |
| Hs 578T | PLX-4720 | 3.1623 | uM | 1 | 625.00 | 382.17 | 1282.00 | 1080.08 | 1.1825 | 1.2397 |
| Hs 578T | Palbociclib | 3.1623 | uM | 1 | 312.50 | 222.17 | 240.67 | 550.00 | 0.4390 | 0.0529 |
| Hs 578T | PLX-4720 | 3.1623 | uM | 1 | 156.25 | 76.08 | 213.00 | 202.42 | 1.0497 | 1.0659 |
| Hs 578T | NVP-TAE684 | 3.1623 | uM | 1 | 156.25 | 76.08 | 48.00 | 202.42 | 0.2401 | -0.2836 |
| Hs 578T | Methotrexate | 3.1623 | uM | 1 | 312.50 | 222.17 | 271.00 | 550.00 | 0.4817 | 0.1160 |
| Hs 578T | Omipalisib | 3.1623 | uM | 1 | 156.25 | 76.08 | 43.33 | 200.08 | 0.2282 | -0.3972 |
| Hs 578T | Methotrexate | 3.1623 | uM | 1 | 156.25 | 76.08 | 119.67 | 200.08 | 0.5482 | 0.1534 |
| Hs 578T | Palbociclib | 3.1623 | uM | 1 | 156.25 | 76.08 | 93.33 | 200.08 | 0.4446 | 0.0088 |
| Hs 578T | Nilotinib | 3.1623 | uM | 1 | 312.50 | 222.17 | 619.67 | 682.08 | 0.9044 | 0.8726 |
| Hs 578T | Omipalisib | 3.1623 | uM | 1 | 312.50 | 222.17 | 133.00 | 550.00 | 0.2426 | -0.3348 |
| Hs 578T | Etoposide | 3.1623 | uM | 1 | 625.00 | 382.17 | 367.00 | 1080.08 | 0.3404 | -0.0440 |
| Hs 578T | PLX-4720 | 3.1623 | uM | 1 | 312.50 | 222.17 | 840.00 | 682.08 | 1.2304 | 1.2741 |
| Hs 578T | Etoposide | 3.1623 | uM | 1 | 156.25 | 76.08 | 72.33 | 202.42 | 0.3595 | -0.0354 |
| Hs 578T | Nilotinib | 3.1623 | uM | 1 | 156.25 | 76.08 | 218.67 | 202.42 | 1.0849 | 1.1249 |
| Hs 578T | Nilotinib | 3.1623 | uM | 1 | 1250.00 | 718.46 | 2252.67 | 2178.67 | 1.0331 | 1.0398 |
| Hs 578T | Etoposide | 3.1623 | uM | 1 | 1250.00 | 718.46 | 914.00 | 2178.67 | 0.4196 | 0.1591 |